Lars Brichta

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

Lars Brichta · Human Molecular Genetics · 2003 · 381 citations

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

Brunhilde Wirth, Lars Brichta, Berthold Schrank et al. · Human Genetics · 2006 · 347 citations

Smn2 Copy Number, Genetic Disorder, Degenerative Disease +5

Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis

Jean-Pierre Roussarie, Vicky Yao, Patricia Rodriguez‐Rodriguez et al. · Neuron · 2020 · 185 citations · Full text

Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

Steven M. Graves, Zhong Xie, Kristen A. Stout et al. · Nature Neuroscience · 2019 · 173 citations

Mitochondrial Function, Biochemistry, Physiology +7

Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons

Benjamin Kolisnyk, Tae Wan Kim, Jia Cheng et al. · Cell stem cell · 2019 · 169 citations · Full text

Cellular Senescence, Neuroscience, Molecular Neurobiology +4